NCT00003256View on ClinicalTrials.gov

Flavopiridol in Treating Patients With Recurrent Prostate Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

May 31, 1998

Primary Completion Date

July 31, 2002

Study Completion Date

April 30, 2004

Conditions
Prostate Cancer
Interventions
DRUG

alvocidib

Trial Locations (4)

53792

University of Wisconsin Comprehensive Cancer Center, Madison

91010

Beckman Research Institute, City of Hope, Duarte

95817

University of California Davis Cancer Center, Sacramento

02115

Dana-Farber Cancer Institute, Boston

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00003256 - Flavopiridol in Treating Patients With Recurrent Prostate Cancer | Biotech Hunter | Biotech Hunter